2019 Commercialization Fellows

Meet the 2019 Commercialization Fellows and learn about the potential real-world impacts of their technological innovations. Read the Cornell Chronicle announcement for additional information on the cohort.

Jake Gemerek
Mechanical Engineering, Ph.D. '20
Sensor Control for Autonomous Perception

A control algorithm for camera networks that can be used to autonomously gather information, such as tracking a person through a crowd, detecting dangerous situations on a construction site, discovering optimal locations to place advertisements and monitoring animal migrations to protect endangered species.

Austin Hickman
Electrical and Computer Engineering, Ph.D. '21
Aluminum Nitride-Based Power Transistor

A transistor that can amplify signals above 100 gigahertz, which is critical for fast data transmission in next-generation (6G) wireless communication systems, as well as in self-driving cars that must map their surroundings in real time. This new level of performance is enabled by the thermal and electrical advantages of aluminum nitride over other materials, such as silicon and gallium nitride.

Jen-Yu Huang
Chemical Engineering, Ph.D. '20
Light-Patternable Porous Material in Microfluidic Devices

A light processing technique to create programmable mesoporous materials – materials with precise patterns of pores – that can be integrated into medical devices for bioseparation and point-of-care diagnostics. Potential applications include creating a device to purify drugs and a device to detect rare cells.

Ariah Klages-Mundt
Applied Mathematics, Ph.D. '21
Designing Decentralized Finance

A platform to test, simulate and design stablecoins – digital cryptocurrencies designed to hold stable trading value. In addition, Klages-Mundt has developed a fundamentally new stablecoin design that involves buffered responses to extreme events such as market fluctuations.

Stephen Sloan
Biomedical Engineering, Ph.D. '20
Injectable Intervertebral Disc Treatment

A high-density collagen gel that can be injected into a patient with spinal cord and nerve root compression due to intervertebral disc degeneration. The gel is engineered to prevent reherniation and promote tissue healing following a procedure that often causes complications after the removal of diseased tissue.